- Report
- October 2024
- 198 Pages
Global
From €3399EUR$3,545USD£2,840GBP
€3776EUR$3,939USD£3,155GBP
- Report
- October 2024
- 83 Pages
Global
From €3500EUR$3,911USD£3,027GBP
- Report
- April 2025
- 50 Pages
Global
From €2540EUR$2,650USD£2,123GBP
Enflurane is an inhalational anesthetic drug used in the induction and maintenance of general anesthesia. It is a halogenated ether, and is one of the most widely used volatile anesthetics in the operating room. Enflurane is a non-flammable, non-explosive anesthetic agent with a low blood/gas partition coefficient, allowing for rapid induction and recovery times. It is also known for its low solubility in blood, which reduces the risk of anesthetic awareness.
Enflurane is used in a variety of surgical procedures, including cardiac, orthopedic, and neurosurgical operations. It is also used in the treatment of chronic pain, and in the management of acute pain in the emergency room.
Enflurane is available in a variety of formulations, including liquid, vaporizer, and aerosol. It is also available in combination with other anesthetic agents, such as nitrous oxide and propofol.
Some companies in the Enflurane market include Baxter International, Hospira, Merck, and Teva Pharmaceuticals. Show Less Read more